Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Choosing the right accounts—taxable, tax-advantaged, or retirement—can significantly reduce taxes on index fund gains and distributions.
25,988 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
SoundHound AI reported its sixth consecutive earnings beat as revenue and AI platform demand accelerate. The LivePers...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
A Two Harbors shareholder files a federal lawsuit to block the CCM merger vote, alleging deceptive proxy disclosures ...
Tim Cook's travels to China are more than diplomacy. This piece outlines how what cook's trip china could mean for Ap...
Bitcoin is trading in a lower gear as institutional demand wanes and macro pressures mount. ETF outflows and tepid on...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Doge price slips toward the 10-cent level as whale buying intensifies. Large holders add hundreds of millions of DOGE...
Nvidia just increased holding in a high-growth AI stock that has climbed nearly 50% this year. This article breaks do...
A new industry focus centers on converting existing leads. Real estate teams report faster traction by prioritizing f...
Bitcoin hovers near the $73,000 mark as Hormuz headlines dominate the weekend. This report explains how bitcoin will ...
As HIVE Digital Technologies prepares to report Q4 results, the stock has surged more than 100% in May. Traders are w...